Results 1 to 10 of about 40,108 (77)
A novel 16-membered-ring macrolide agent (CP-163,505, a reductive amination derivative of repromicin) was identified as an antibacterial against Pasteurella haemolytica, P. multocida and Actinobacillus pleuropneumoniae, important etiological agents of livestock respiratory disease. In vitro MIC50/90 analysis revealed that CP-163,505 was more potent (4x)
L J, Norcia +8 more
openaire +4 more sources
Two cyclic homopentapeptides, CP-101,680 and CP-163,234 [6a-(3',4'-dichlorophenylamino) analogs of viomycin and capreomycin, respectively], were identified as novel antibacterial agents for the treatment of animal disease, especially for livestock respiratory disease.
L J, Norcia +6 more
openaire +3 more sources
Some of the next articles are maybe not open access.
ChemInform, 2000
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Laura J. L. Norcia +6 more
openaire +1 more source
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Laura J. L. Norcia +6 more
openaire +1 more source
Journal of Antimicrobial Chemotherapy, 1989
A group of 21 patients admitted to hospital with acute purulent exacerbations of chronic bronchitis was treated for five days with a new oral macrolide azithromycin. They received one dose of 500 mg on the first day, followed by 250 mg once daily thereafter. Pre-treatment sputum cultures were typical for this district, but the cultures during and after
B I, Davies, F P, Maesen, R, Gubbelmans
openaire +2 more sources
A group of 21 patients admitted to hospital with acute purulent exacerbations of chronic bronchitis was treated for five days with a new oral macrolide azithromycin. They received one dose of 500 mg on the first day, followed by 250 mg once daily thereafter. Pre-treatment sputum cultures were typical for this district, but the cultures during and after
B I, Davies, F P, Maesen, R, Gubbelmans
openaire +2 more sources
Clinical pharmacy, 2016
Background In 2014, new expert recommendations on treatment of intra-abdominal infections (IAI) were published. They highlighted the importance of starting empiric antibiotic therapy considering the local microbiological resistance profile and the community acquired or nosocomial character of the infection. Purpose The goal was to analyse antibiotic
M Gougeon +6 more
openaire +1 more source
Background In 2014, new expert recommendations on treatment of intra-abdominal infections (IAI) were published. They highlighted the importance of starting empiric antibiotic therapy considering the local microbiological resistance profile and the community acquired or nosocomial character of the infection. Purpose The goal was to analyse antibiotic
M Gougeon +6 more
openaire +1 more source
The shift from "MIC-Only" back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance. [PDF]
Simner PJ.
europepmc +1 more source
Use of ELISA to predict high <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i> shedding in faeces of infected animals. [PDF]
Fichtelová V +3 more
europepmc +1 more source
The innate immune protein calprotectin ablates the bactericidal activity of β-lactam antibiotics. [PDF]
Velez AZ +12 more
europepmc +1 more source

